Why the study?
Does the presence of polymyalgia rheumatica and/or giant cell arteritis increase the risk of incident cardiovascular diseases in an unselected population?
Cohort (n=117,071)
Yes
Does the presence of polymyalgia rheumatica and/or giant cell arteritis increase the risk of incident cardiovascular diseases in an unselected population?
Answers are grounded in this paper and cite their sources.
In a large population-based cohort, the presence of polymyalgia rheumatica and/or giant cell arteritis was not associated with an increased risk of cardiovascular or cerebrovascular diseases.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Webb et al. (1986) conducted a cohort in Polymyalgia rheumatica and giant cell arteritis (n=117,071). Polymyalgia rheumatica and/or giant cell arteritis vs. Individuals without PMR/GCA was evaluated on First clinical presentation of cardiovascular diseases.
Synapse has enriched 10 related papers. Consider them for comparative context: